Glaxosmithkline Consumer Healthcare

Over the counter health care and consumer products company.

Based in NJ

🤖

AI Overview

With $170K in lobbying spend across 6 quarterly filings, Glaxosmithkline Consumer Healthcare is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2021 to 2022.

$170K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2021	$160K
2022	$10K

Issues Lobbied

Health Issues Taxation Budget/Appropriations TOB Medicare/Medicaid Trade

Lobbying Firms

Faegre Drinker Biddle & Reath LLP

Lobbyists

Ilisa Halpern Paul Jim Twaddell Laura Hanen Jennifer Taylor Mcbride

Government Agencies Targeted

These are the government entities that Glaxosmithkline Consumer Healthcare disclosed contacting in their lobbying filings.

Agency for Healthcare Research & Quality (AHRQ)Commerce, Dept of (DOC)HOUSE OF REPRESENTATIVESIntl Trade Administration (ITA)SENATEWhite House OfficeCenters For Disease Control & Prevention (CDC)Centers For Medicare and Medicaid Services (CMS)Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation, Budget/Appropriations, TOB, Medicare/Medicaid and 1 more

Tobacco cessation; Oral Health; Dietary Supplements; FDA OTC Policy; HSAs/FSAs; Budget: Appropriations for CDC oral health, chronic disease, and tobacco cessation programs.

Dietary Supplement Eligible Expenses under HSAs/FSAs; H.R. 295, the Pandemic Healthcare Access Act; S. 128, the Primary Care Enhancement Act of 2021; S. 380, the Health Savings Act of 2021.